A case of small-cell lung cancer harboring an epidermal growth factor receptor mutation that responded to epidermal growth factor receptor tyrosine kinase inhibitor treatment
| Autor: | Cheng Lung Hsu, Chih We Wang, Ching Fu Chang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Cultural Studies
Linguistics and Language History Mutation biology business.industry Afatinib medicine.disease_cause medicine.disease humanities Language and Linguistics respiratory tract diseases Egfr tki Egfr mutation Anthropology medicine Cancer research biology.protein Non small cell Epidermal growth factor receptor business Lung cancer neoplasms medicine.drug Epidermal growth factor receptor tyrosine kinase |
| Zdroj: | Journal of Cancer Research and Practice. 7:78 |
| ISSN: | 2311-3006 |
| DOI: | 10.4103/jcrp.jcrp_31_19 |
| Popis: | Epidermal growth factor receptor (EGFR) mutations are extremely rare in small-cell lung cancer (SCLC), and the efficacy of EGFR tyrosine kinase inhibitors (TKIs) in SCLC is unclear. Herein, we present a case with SCLC harboring an EGFR mutation who also responded to a second-generation EGFR TKI (afatinib). |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|